JP2020503357A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020503357A5 JP2020503357A5 JP2019536222A JP2019536222A JP2020503357A5 JP 2020503357 A5 JP2020503357 A5 JP 2020503357A5 JP 2019536222 A JP2019536222 A JP 2019536222A JP 2019536222 A JP2019536222 A JP 2019536222A JP 2020503357 A5 JP2020503357 A5 JP 2020503357A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- salt
- synthetic
- active ingredient
- caprilate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 21
- 229930003827 cannabinoid Natural products 0.000 claims 13
- 239000003557 cannabinoid Substances 0.000 claims 13
- 150000003839 salts Chemical class 0.000 claims 12
- 238000000034 method Methods 0.000 claims 11
- 239000004480 active ingredient Substances 0.000 claims 8
- 150000001768 cations Chemical class 0.000 claims 8
- 125000003816 2-hydroxybenzoyl group Chemical group OC1=C(C(=O)*)C=CC=C1 0.000 claims 7
- 238000009472 formulation Methods 0.000 claims 7
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 claims 7
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 7
- 150000001413 amino acids Chemical class 0.000 claims 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 5
- 239000011734 sodium Substances 0.000 claims 5
- 229910052708 sodium Inorganic materials 0.000 claims 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 5
- 150000001875 compounds Chemical class 0.000 claims 4
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 claims 4
- 229940065144 cannabinoids Drugs 0.000 claims 3
- 229910052751 metal Inorganic materials 0.000 claims 3
- 239000002184 metal Substances 0.000 claims 3
- 150000002892 organic cations Chemical class 0.000 claims 3
- XONUSAAXQLCRGJ-UHFFFAOYSA-N 2,3,3a,4-tetrahydro-1h-pyrazolo[3,4-c]pyridine Chemical compound N1=CCC2CNNC2=C1 XONUSAAXQLCRGJ-UHFFFAOYSA-N 0.000 claims 2
- PQCVYHSKABCYON-UHFFFAOYSA-N 2-oxo-1h-pyridine-3-carboxamide Chemical compound NC(=O)C1=CC=CN=C1O PQCVYHSKABCYON-UHFFFAOYSA-N 0.000 claims 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims 2
- CYQFCXCEBYINGO-UHFFFAOYSA-N THC Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 CYQFCXCEBYINGO-UHFFFAOYSA-N 0.000 claims 2
- QHMBSVQNZZTUGM-UHFFFAOYSA-N Trans-Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-UHFFFAOYSA-N 0.000 claims 2
- 239000011575 calcium Substances 0.000 claims 2
- 229910052791 calcium Inorganic materials 0.000 claims 2
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 claims 2
- 229950011318 cannabidiol Drugs 0.000 claims 2
- ZTGXAWYVTLUPDT-UHFFFAOYSA-N cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-UHFFFAOYSA-N 0.000 claims 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 2
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 claims 2
- PCXRACLQFPRCBB-ZWKOTPCHSA-N dihydrocannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)C)CCC(C)=C1 PCXRACLQFPRCBB-ZWKOTPCHSA-N 0.000 claims 2
- -1 lipid amide compound Chemical class 0.000 claims 2
- 239000011777 magnesium Substances 0.000 claims 2
- 229910052749 magnesium Inorganic materials 0.000 claims 2
- GECBBEABIDMGGL-RTBURBONSA-N nabilone Chemical compound C1C(=O)CC[C@H]2C(C)(C)OC3=CC(C(C)(C)CCCCCC)=CC(O)=C3[C@@H]21 GECBBEABIDMGGL-RTBURBONSA-N 0.000 claims 2
- 229960002967 nabilone Drugs 0.000 claims 2
- 239000011591 potassium Substances 0.000 claims 2
- 229910052700 potassium Inorganic materials 0.000 claims 2
- 150000003230 pyrimidines Chemical class 0.000 claims 2
- 150000003505 terpenes Chemical class 0.000 claims 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims 1
- XXGMIHXASFDFSM-UHFFFAOYSA-N Delta9-tetrahydrocannabinol Natural products CCCCCc1cc2OC(C)(C)C3CCC(=CC3c2c(O)c1O)C XXGMIHXASFDFSM-UHFFFAOYSA-N 0.000 claims 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims 1
- 229960004242 dronabinol Drugs 0.000 claims 1
- KROMVFOLXQGWAC-UHFFFAOYSA-N pyrido[3,2-e]-1,2,4-triazolo[4,3-c]pyrimidine Chemical compound C1=CN=C2N=CN3C=NN=C3C2=C1 KROMVFOLXQGWAC-UHFFFAOYSA-N 0.000 claims 1
- 230000002194 synthesizing effect Effects 0.000 claims 1
- 235000007586 terpenes Nutrition 0.000 claims 1
- QEMXHQIAXOOASZ-UHFFFAOYSA-N tetramethylammonium Chemical compound C[N+](C)(C)C QEMXHQIAXOOASZ-UHFFFAOYSA-N 0.000 claims 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023018922A JP7466238B2 (ja) | 2017-01-03 | 2023-02-10 | 医薬化合物及び栄養補給剤 |
| JP2024047771A JP2024075724A (ja) | 2017-01-03 | 2024-03-25 | 医薬化合物及び栄養補給剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762441908P | 2017-01-03 | 2017-01-03 | |
| US62/441,908 | 2017-01-03 | ||
| PCT/US2018/012261 WO2018129097A1 (en) | 2017-01-03 | 2018-01-03 | Medicinal compounds and nutritional supplements |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023018922A Division JP7466238B2 (ja) | 2017-01-03 | 2023-02-10 | 医薬化合物及び栄養補給剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020503357A JP2020503357A (ja) | 2020-01-30 |
| JP2020503357A5 true JP2020503357A5 (https=) | 2021-02-12 |
| JP7281815B2 JP7281815B2 (ja) | 2023-05-26 |
Family
ID=62790943
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019536222A Active JP7281815B2 (ja) | 2017-01-03 | 2018-01-03 | 医薬化合物及び栄養補給剤 |
| JP2023018922A Active JP7466238B2 (ja) | 2017-01-03 | 2023-02-10 | 医薬化合物及び栄養補給剤 |
| JP2024047771A Pending JP2024075724A (ja) | 2017-01-03 | 2024-03-25 | 医薬化合物及び栄養補給剤 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023018922A Active JP7466238B2 (ja) | 2017-01-03 | 2023-02-10 | 医薬化合物及び栄養補給剤 |
| JP2024047771A Pending JP2024075724A (ja) | 2017-01-03 | 2024-03-25 | 医薬化合物及び栄養補給剤 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20190336472A1 (https=) |
| EP (1) | EP3565539A4 (https=) |
| JP (3) | JP7281815B2 (https=) |
| KR (1) | KR20190103302A (https=) |
| CN (1) | CN110121337A (https=) |
| AU (2) | AU2018206564B2 (https=) |
| BR (1) | BR112019013743A2 (https=) |
| CA (1) | CA3049226A1 (https=) |
| CL (1) | CL2019001832A1 (https=) |
| CO (1) | CO2019008176A2 (https=) |
| EA (1) | EA201991641A1 (https=) |
| IL (1) | IL267831A (https=) |
| MX (1) | MX2019007968A (https=) |
| WO (1) | WO2018129097A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11180781B2 (en) * | 2016-08-21 | 2021-11-23 | Insectergy, Llc | Biosynthetic cannabinoid production methods |
| BR112018071518A2 (pt) | 2016-04-22 | 2019-02-19 | Receptor Life Sciences, Inc. | compostos medicinais à base de planta de ação rápida e suplementos nutricionais |
| EA201892396A1 (ru) | 2016-12-02 | 2019-04-30 | Ресептор Лайф Сайенсиз, Инк. | Быстродействующие растительные лекарственные соединения и биологически активные добавки |
| US20190336472A1 (en) * | 2017-01-03 | 2019-11-07 | Receptor Holdings, Inc. | Medicinal compounds and nutritional supplements |
| US20210052544A1 (en) * | 2018-01-29 | 2021-02-25 | Solantech Inc. | Methods of treating and/or preventing bedsores using nabilone |
| BR112021006858A2 (pt) * | 2018-10-10 | 2021-07-13 | Tilray Inc. | métodos e formulações para tratar náusea e vômito induzidos por quimioterapia |
| EP3883595A4 (en) | 2018-11-19 | 2022-12-14 | Receptor Holdings, Inc. | N-ACYLATED FATTY AMINO ACIDS TO REDUCE ABSORPTION VARIABILITY IN CANNABINOID-BASED COMPOSITIONS |
| US11622956B1 (en) | 2019-06-26 | 2023-04-11 | RCR BioPharma | Compound and method for treating diseases and disorders |
| EP3946262B1 (en) | 2019-08-30 | 2024-07-31 | Evie Sa | Loaded granules, their process of production and their uses |
| US12171872B2 (en) | 2019-12-09 | 2024-12-24 | Nicoventures Trading Limited | Oral compositions and methods of manufacture |
| EP4072338A1 (en) | 2019-12-09 | 2022-10-19 | Nicoventures Trading Limited | Agents for oral composition |
| CN113040337B (zh) * | 2021-04-22 | 2022-12-09 | 四川大学 | 一种熏肉制品及其制备方法 |
| WO2024253228A1 (ko) * | 2023-06-09 | 2024-12-12 | 주식회사 메타파인즈 | 악액질 및 근손실의 예방 또는 치료용 조성물 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001523221A (ja) | 1996-09-01 | 2001-11-20 | ファーモス コーポレイション | 親油性物質の促進された生物学的利用能のための固形共沈物 |
| CA2466863A1 (en) * | 2001-11-29 | 2003-06-05 | Emisphere Technologies, Inc. | Oral pharmaceutical compositions comprising cromolyn sodium and an acylated amino acid |
| WO2008033024A2 (en) | 2006-09-15 | 2008-03-20 | Echo Pharmaceuticals B.V. | Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances |
| SG190024A1 (en) | 2010-11-25 | 2013-06-28 | Aop Orphan Pharmaceuticals Ag | Fast disintegrating compositions comprising nabilone and randomly methylated beta cyclodextrin |
| US20130224300A1 (en) * | 2011-08-26 | 2013-08-29 | Edward T. Maggio | Compositions and methods thereof for oral administration of drugs |
| CA2845443A1 (en) * | 2014-03-04 | 2015-09-04 | Pharmascience Inc. | Orally disintegrating tablet of nabilone and method of manufacturing |
| BR112018071518A2 (pt) | 2016-04-22 | 2019-02-19 | Receptor Life Sciences, Inc. | compostos medicinais à base de planta de ação rápida e suplementos nutricionais |
| US20190336472A1 (en) * | 2017-01-03 | 2019-11-07 | Receptor Holdings, Inc. | Medicinal compounds and nutritional supplements |
-
2018
- 2018-01-03 US US16/474,480 patent/US20190336472A1/en not_active Abandoned
- 2018-01-03 BR BR112019013743-2A patent/BR112019013743A2/pt not_active Application Discontinuation
- 2018-01-03 MX MX2019007968A patent/MX2019007968A/es unknown
- 2018-01-03 WO PCT/US2018/012261 patent/WO2018129097A1/en not_active Ceased
- 2018-01-03 CA CA3049226A patent/CA3049226A1/en active Pending
- 2018-01-03 KR KR1020197022846A patent/KR20190103302A/ko not_active Ceased
- 2018-01-03 EP EP18736204.1A patent/EP3565539A4/en not_active Withdrawn
- 2018-01-03 EA EA201991641A patent/EA201991641A1/ru unknown
- 2018-01-03 JP JP2019536222A patent/JP7281815B2/ja active Active
- 2018-01-03 AU AU2018206564A patent/AU2018206564B2/en active Active
- 2018-01-03 CN CN201880005658.8A patent/CN110121337A/zh active Pending
-
2019
- 2019-07-02 CL CL2019001832A patent/CL2019001832A1/es unknown
- 2019-07-03 IL IL267831A patent/IL267831A/en unknown
- 2019-07-29 CO CONC2019/0008176A patent/CO2019008176A2/es unknown
-
2022
- 2022-06-07 US US17/834,798 patent/US20230293479A1/en not_active Abandoned
-
2023
- 2023-02-10 JP JP2023018922A patent/JP7466238B2/ja active Active
-
2024
- 2024-02-20 AU AU2024201078A patent/AU2024201078A1/en active Pending
- 2024-03-25 JP JP2024047771A patent/JP2024075724A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020503357A5 (https=) | ||
| JP2022031762A5 (https=) | ||
| EA201070841A1 (ru) | НОВЫЕ ПИРАЗОЛО[3,4-d]ПИРИМИДИНОВЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ПРОТИВОРАКОВЫХ ЛЕКАРСТВЕННЫХ СРЕДСТВ | |
| JP2013518036A5 (https=) | ||
| EP2151241A4 (en) | STABLE SOLID PREPARATION WITH 4,5-EPOXYMORPHINANE DERIVATIVE | |
| WO2009007137A3 (en) | Pharmaceutical composition for topical application of poorly soluble compounds | |
| HRP20160802T1 (hr) | Čvrsti farmaceutski pripravci koji sadrže derivate biopterina i upotreba takvih pripravaka | |
| JP2019526634A5 (https=) | ||
| RU2010110603A (ru) | Высококонцентрированные препараты 1-метилгептилового эфира флуроксипира, стабильные при низких температурах | |
| RU2014116395A (ru) | Соединения, композиции и способы для снижения или устранения горького вкуса | |
| HRP20190783T1 (hr) | Farmaceutske formulacije | |
| CN1203600A (zh) | 二氨基嘧啶,含它们的药物组合物和其作为抗菌药物的用途 | |
| EP1634883A4 (en) | 2-SUBSTITUTED PHENYL-5,7-DIALKYL-3,7-DIHYDROPYRROLO-2,3-PYRIMIDIN-4-ONDERIVATES, THEIR PREPARATION AND PHARMACEUTICAL USE | |
| CA2546643A1 (en) | Isoflavonoid prodrugs, compositions thereof and therapeutic methods involving same | |
| RU2018117499A (ru) | Производные 6-[5-амино-6-(2-этоксиэтокси)-имидазо[4,5-b]пиридин-3-ил]никотинонитрила и их применение в качестве irak ингибиторов | |
| ECSP067111A (es) | Derivados de pirido-pirimidina, su preparación, su aplicación en terapéutica | |
| JP7286631B2 (ja) | 医療用葉酸塩 | |
| EA202190036A1 (ru) | Кристаллическая форма соединения для ингибирования активности cdk4/6 и ее применение | |
| RU2008121716A (ru) | Препараты | |
| RU2007136782A (ru) | Ингибирующие вич 2-(4-цианофенил)-6-гидроксиламинопиримидины | |
| HRP20200472T1 (hr) | Liječenje alopecije areate | |
| JP5611089B2 (ja) | 水性液体口腔用組成物 | |
| JP7621107B2 (ja) | コレカルシフェロール硫酸塩及びビタミンｄ欠乏症の処置のためのこれらの使用 | |
| JP2008524259A5 (https=) | ||
| EP3636642A8 (en) | Indoleacetic acid derivative and preparation method and pharmaceutical use thereof |